Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gonadal Steroid Hormones | 1 | 2026 | 36 | 0.230 |
Why?
|
| Sesterterpenes | 2 | 2015 | 2 | 0.220 |
Why?
|
| Claudin-5 | 1 | 2024 | 3 | 0.220 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2024 | 8 | 0.220 |
Why?
|
| Cadmium | 1 | 2024 | 12 | 0.220 |
Why?
|
| Estradiol | 1 | 2026 | 260 | 0.210 |
Why?
|
| Cell Adhesion | 1 | 2024 | 218 | 0.210 |
Why?
|
| Islets of Langerhans | 1 | 2026 | 286 | 0.210 |
Why?
|
| Keratan Sulfate | 2 | 2013 | 2 | 0.190 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2013 | 4 | 0.190 |
Why?
|
| Gene Expression | 1 | 2026 | 856 | 0.180 |
Why?
|
| Pseudomonas Infections | 2 | 2013 | 73 | 0.180 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2013 | 132 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2026 | 738 | 0.140 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 81 | 0.140 |
Why?
|
| Endoscopy | 1 | 2019 | 92 | 0.140 |
Why?
|
| Urban Population | 1 | 2019 | 201 | 0.140 |
Why?
|
| Obesity | 1 | 2026 | 1281 | 0.130 |
Why?
|
| Octamer Transcription Factors | 1 | 2015 | 2 | 0.120 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2015 | 13 | 0.120 |
Why?
|
| Insulin | 2 | 2026 | 697 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 157 | 0.110 |
Why?
|
| Photoaffinity Labels | 1 | 2014 | 5 | 0.100 |
Why?
|
| Keratitis | 1 | 2013 | 19 | 0.090 |
Why?
|
| Hypoxia | 1 | 2014 | 121 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 39 | 0.090 |
Why?
|
| Macrophages, Peritoneal | 1 | 2012 | 75 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 446 | 0.090 |
Why?
|
| Pneumonia, Bacterial | 1 | 2012 | 91 | 0.090 |
Why?
|
| Fas Ligand Protein | 1 | 2011 | 40 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2012 | 257 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2011 | 165 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 645 | 0.070 |
Why?
|
| Ghrelin | 1 | 2007 | 18 | 0.070 |
Why?
|
| Caloric Restriction | 1 | 2007 | 21 | 0.070 |
Why?
|
| Stomach | 1 | 2007 | 87 | 0.060 |
Why?
|
| Receptors, Leptin | 1 | 2026 | 15 | 0.060 |
Why?
|
| Orchiectomy | 1 | 2026 | 40 | 0.060 |
Why?
|
| Ovariectomy | 1 | 2026 | 104 | 0.060 |
Why?
|
| Animals | 7 | 2026 | 21493 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2024 | 22 | 0.050 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 46 | 0.050 |
Why?
|
| Mice | 6 | 2015 | 11185 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2026 | 216 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2015 | 315 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2024 | 326 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2026 | 502 | 0.050 |
Why?
|
| Lumican | 2 | 2013 | 2 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2024 | 216 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2026 | 2329 | 0.050 |
Why?
|
| Rats | 1 | 2026 | 2005 | 0.040 |
Why?
|
| Aging | 1 | 2007 | 784 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2013 | 664 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 449 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 96 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 514 | 0.040 |
Why?
|
| Helicobacter Infections | 1 | 2019 | 55 | 0.040 |
Why?
|
| Helicobacter pylori | 1 | 2019 | 58 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1044 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2013 | 2168 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 42 | 0.030 |
Why?
|
| Female | 4 | 2026 | 34425 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 233 | 0.030 |
Why?
|
| Cisplatin | 1 | 2015 | 145 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 206 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 44 | 0.030 |
Why?
|
| Mass Screening | 1 | 2019 | 700 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 426 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 357 | 0.020 |
Why?
|
| CD18 Antigens | 1 | 2012 | 30 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 302 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 859 | 0.020 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2012 | 145 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 466 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 238 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2739 | 0.020 |
Why?
|
| Humans | 4 | 2024 | 65845 | 0.020 |
Why?
|
| Male | 2 | 2026 | 31410 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2012 | 190 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 122 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1638 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 147 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 1332 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2011 | 206 | 0.020 |
Why?
|
| Immune System | 1 | 2011 | 133 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 526 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 625 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 1226 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 676 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5682 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1292 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2007 | 29 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6957 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 1012 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 899 | 0.010 |
Why?
|
| Neoplasms | 1 | 2015 | 1378 | 0.010 |
Why?
|
| Mutation | 1 | 2011 | 2675 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 15147 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 17579 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 18501 | 0.010 |
Why?
|